Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000329
Filing Date
2025-03-13
Accepted
2025-03-13 06:50:22
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clrb-20241231x10k.htm   iXBRL 10-K 2378153
2 EX-19.1 clrb-20241231xex19d1.htm EX-19.1 41059
3 EX-21.1 clrb-20241231xex21d1.htm EX-21.1 3018
4 EX-23.1 clrb-20241231xex23d1.htm EX-23.1 2558
5 EX-31.1 clrb-20241231xex31d1.htm EX-31.1 10967
6 EX-31.2 clrb-20241231xex31d2.htm EX-31.2 10977
7 EX-32.1 clrb-20241231xex32d1.htm EX-32.1 5857
8 GRAPHIC clrb-20241231xex19d1001.jpg GRAPHIC 5659
  Complete submission text file 0001410578-25-000329.txt   8743995

Data Files

Seq Description Document Type Size
9 EX-101.SCH clrb-20241231.xsd EX-101.SCH 52357
10 EX-101.CAL clrb-20241231_cal.xml EX-101.CAL 56018
11 EX-101.DEF clrb-20241231_def.xml EX-101.DEF 223276
12 EX-101.LAB clrb-20241231_lab.xml EX-101.LAB 426377
13 EX-101.PRE clrb-20241231_pre.xml EX-101.PRE 380307
83 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20241231x10k_htm.xml XML 1365763
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36598 | Film No.: 25733793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)